Overview

Diffuse Optical Spectroscopy Imaging in Monitoring and Predicting Response in Patients With Locally Advanced Breast Cancer Undergoing Chemotherapy Before Surgery

Status:
Unknown status

Trial end date:
0000-00-00

Target enrollment:

Participant gender:

Summary

RATIONALE: New imaging procedures, such as diffuse optical spectroscopy imaging, may help measure a patient's response and allow doctors to plan better treatment. PURPOSE: This clinical trial studies diffuse optical spectroscopy imaging in monitoring and predicting response in patients with locally advanced breast cancer undergoing chemotherapy before surgery.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

American College of Radiology Imaging Network

Collaborator:

National Cancer Institute (NCI)